EBA
SUPN icon

Eagle Bay Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History

Eagle Bay Advisors’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-156
Closed -$5.64K – 847
2024
Q4 		$5.64K Buy
156
+7
+5% +$246 ﹤0.01% 682
2024
Q3 		$4.65K Sell
149
-80
-35% -$2.5K ﹤0.01% 1031
2024
Q2 		$6.13K Sell
229
-56
-20% -$1.62K ﹤0.01% 660
2024
Q1 		$9.72K Sell
285
-116
-29% -$3.45K 0.01% 592
2023
Q4 		$11.6K Sell
401
-2,811
-88% -$74.5K 0.01% 499
2023
Q3 		$88.6K Buy
3,212
+984
+44% +$30K 0.04% 275
2023
Q2 		$67K Sell
2,228
-572
-20% -$20K 0.04% 310
2023
Q1 		$101K Sell
2,800
-386
-12% -$14.8K 0.06% 233
2022
Q4 		$114K Buy
3,186
+515
+19% +$17.9K 0.06% 210
2022
Q3 		$91K Buy
2,671
+8
+0.3% +$260 0.06% 218
2022
Q2 		$77K Buy
2,663
+1,567
+143% +$44.9K 0.05% 257
2022
Q1 		$35K Sell
1,096
-348
-24% -$10.7K 0.03% 184
2021
Q4 		$42K Buy
1,444
+750
+108% +$22.8K 0.03% 421
2021
Q3 		$18K Sell
694
-489
-41% -$13.1K 0.01% 638
2021
Q2 		$39K Buy
+1,183
New +$36.3K 0.03% 400

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Eagle Bay Advisors's SUPN Position: Q1 2025 in Review

Eagle Bay Advisors sold out of Supernus Pharmaceuticals (SUPN) in Q1 2025, closing a stake of 156 shares — an estimated $5.64K sold.

Eagle Bay Advisors first reported a position in SUPN in Q2 2021 and held it in 15 quarters. The position peaked at $114K in Q4 2022. 295 funds tracked by Wall St. Rank hold SUPN as of Q1 2025.

  • Eagle Bay Advisors reported no remaining Supernus Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Eagle Bay Advisors sold 156 Supernus Pharmaceuticals shares in Q1 2025, an estimated $5.64K.
  • Eagle Bay Advisors first reported a position in Supernus Pharmaceuticals in Q2 2021 and held it in 15 quarters.
  • Eagle Bay Advisors's Supernus Pharmaceuticals position peaked at $114K in Q4 2022.
  • 295 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2025.

Based on Eagle Bay Advisors's 13F filing for Q1 2025, filed 5 May 2025.